Page 6 - Long Wu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SAN FRANCISCO and SUZHOU, China, May 16, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, today announced that the company will present clinical data from multiple trials in relation to TYVYT® (sintilimab injection), Pemazyre®...

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

8月3日上午8点，中国田径队队员吴瑞庭踏上东京奥运会男子三级跳远资格赛的赛场。对于自己的首次奥运征程，这个来自东莞大朗的“95后”帅小伙坦言：“很兴奋，尽力就好！”而在他的家乡——大朗镇松柏朗村，父母和乡亲们正围坐在村委会电视机旁，收看比赛实况。 北京时间8月3日上午8点（东京当地时间9点）进行的男子三级跳远资格赛，分为A、B两组同时进行，各有16名选手参加。三名中国选手中，吴瑞庭位于A组，第5位出场。 1995年11月29日出�...

 E-Mail (Singapore--16:45 p.m. SPT/3:45 EST January 29, 2021)--Two presentations from the ADAURA clinical trial advanced previous research that demonstrated improved disease-fee survival (DFS) outcomes for patients with surgically resected non-small cell lung cancer (NSCLC) receiving osimertinib. The data were reported today at the International Association for the Study of Lung Cancer's 2020 World Conference on Lung Cancer (WCLC) Singapore. Osimertinib is a third-generation, irreversible, central nervous system-active, epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor. ADAU...

  In the ADAURA Phase III trial, chemotherapy use was balanced across the two treatment arms, with 60% of patients receiving prior adjuvant chemotherapy. In line with uptake observed in prior studies and clinical practice, younger patients (